Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: Implications with neuronal vulnerability in Huntington's disease

European Journal of Neuroscience

Volumn 23, Issue 1, 2006, Pages 11-20

  Giampà, Carmela ^a   DeMarch, Zena ^a   D'Angelo, Vincenza ^b   Morello, Maria ^b   Martorana, Alessandro ^a,b   Sancesario, Giuseppe ^a,b   Bernardi, Giorgio ^a,b   Fusco, Francesca R ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

CREB; Quinolinic acid; Rats; Striatum

Indexed keywords

CALRETININ; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PARVALBUMIN; PROTEIN ANTIBODY; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE PREDISPOSITION; EXCITOTOXICITY; HUNTINGTON CHOREA; IMMUNOFLUORESCENCE; INTERNEURON; MALE; NERVE CELL; NERVE PROJECTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL COUNT; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; GENE EXPRESSION REGULATION; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NITRIC OXIDE SYNTHASE; PARVALBUMINS; QUINOLINIC ACID; RATS; RATS, WISTAR; TIME FACTORS;

EID: 33644956493     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04545.x     Document Type: Article

References (53)

1. Albin RL. Reiner A. Anderson KD. Penney JB. Young AB. 1990a Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia AnnNeurol 27 357 365 q11
2. Albin RL. Young AB. Penney JB. Handelin B. Balfour R. Anderson KD. Markel DS. Tourtellotte WW. Reiner A. 1990b Abnormalities of striatal projection neurons and N-methyl- d -aspartate receptors in presymptomatic Huntington's disease NEnglJMed 322 1293 1298
3. Albin RL. Reiner A. Anderson KD. Dure LS. Handelin B. Balfour R. Whetsell WO. Jr. Penney JB. Young AB. 1992 Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease AnnNeurol 31 425 430
4. Albin RL. Tagle DA. 1995 Genetics and molecular biology of Huntington's disease TINS 18 11 14
5. Alexi T. Hughes PE. Roon-Mom WM. Faull RL. Williams CE. Clark RG. Gluckman PD. 1999 The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease ExpNeurol 159 84 97
6. Calabresi P. Centonze D. Bernardi G. 2000a Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum Neurology 55 1249 1255 q12
7. Calabresi P. Centonze D. Gubellini P. Pisani A. Bernardi G. 2000b Acetylcholine-mediated modulation of striatal function TINS 23 120 126
8. Chiang MC. Lee YC. Huang CL. Chern Y. 2005 cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant huntingtin with expanded polyglutamine residues JBiolChem 280 14331 14340
9. Cicchetti F. Parent A. 1996 Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons MovDisord 11 619 626
10. Cramer H. Warter JM. Renaud B. 1984 Analysis of neurotransmitter metabolites and adenosine 3′,5′-monophosphate in the CSF of patients with extrapyramidal motor disorders AdvNeurol 40 431 435
11. de la Monte SM. Vonsattel JP. Richardson EP. Jr. 1988 Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease JNeuropatholExpNeurol 47 516 525 q13
12. DiFiglia M. Sapp E. Chase KO. Davies SW. Bates GP. Vonsattel JP. Aronin N. 1997 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain Science 277 1990 1993
13. Ferrante RJ. Beal MF. Kowall NW. Richardson EP. Jr. Martin JB. 1987 Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease Brain Res 411 162 166
14. Ferrante RJ. Kowall NW. Beal MF. Richardson EP. Jr. Bird ED. Martin JB. 1985 Selective sparing of a class of striatal neurons in Huntington's disease Science 230 561 563
15. Ferrante RJ. Kowall NW. Richardson EP. Jr. Bird ED. Martin JB. 1986 Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum NeurosciLett 71 283 288
16. Ferrer I. Blanco R. Carmona M. Puig B. 2001 Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies JNeural Transm 108 1397 1415
17. Figueredo-Cardenas G. Anderson KD. Chen Q. Veenman CL. Reiner A. 1994 Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats ExpNeurol 129 37 56
18. Figueredo-Cardenas G. Chen Q. Reiner A. 1997 Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats ExpNeurol 146 444 457
19. Figueredo-Cardenas G. Harris CL. Anderson KD. Reiner A. 1998 Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types ExpNeurol 149 356 372
20. Fusco FR. Chen Q. Lamoreaux WJ. Figueredo-Cardenas G. Jiao Y. Coffman JA. Surmeier DJ. Honig MG. Carlock LR. Reiner A. 1999 Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease JNeurosci 19 1189 1202
21. Fusco FR. Martorana A. De March Z. Viscomi MT. Sancesario G. Bernardi G. 2003a Huntingtin distribution among striatal output neurons of normal rat brain NeurosciLett 339 53 56 q14
22. Fusco FR. Zuccato C. Tartari M. Martorana A. De March Z. Giampa C. Cattaneo E. Bernardi G. 2003b Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain EurJNeurosci 18 1093 1102
23. Gines S. Seong IS. Fossale E. Ivanova E. Trettel F. Gusella JF. Wheeler VC. Persichetti F. MacDonald ME. 2003 Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice HumMolGenet 12 497 508
24. Hardingham GE. Cruzalegui FH. Chawla S. Bading H. 1998 Mechanisms controlling gene expression by nuclear calcium signals Cell Calcium 23 131 134
25. Hughes PE. Alexi T. Williams CE. Clark RG. Gluckman PD. 1999 Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease Neuroscience 92 197 209
26. Jiang H. Nucifora FC. Jr. Ross CA. DeFranco DB. 2003 Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein HumMolGenet 12 1 12
27. Kazantsev A. Preisinger E. Dranovsky A. Goldgaber D. Housman D. 1999 Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells ProcNatl AcadSciUSA 96 11404 11409
28. Kopnisky KL. Chalecka-Franaszek E. Gonzalez-Zulueta M. Chuang DM. 2003 Chronic lithium treatment antagonizes glutamate-induced decrease of phosphorylated CREB in neurons via reducing protein phosphatase 1 and increasing MEK activities Neuroscience 116 425 435
29. Kreibich AS. Blendy JA. 2004 cAMP response element-binding protein is required for stress but not cocaine-induced reinstatement JNeurosci 24 6686 6692
30. Liu FC. Graybiel AM. 1996 Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum Neuron 17 1133 1144
31. Lonze BE. Ginty DD. 2002 Function and regulation of CREB family transcription factors in the nervous system Neuron 35 605 623
32. Lonze BE. Riccio A. Cohen S. Ginty DD. 2002 Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB Neuron 34 371 385
33. Luthi-Carter R. Strand A. Peters NL. Solano SM. Hollingsworth ZR. Menon AS. Frey AS. Spektor BS. Penney EB. Schilling G. Ross CA. Borchelt DR. Tapscott SJ. Young AB. Cha JH. Olson JM. 2000 Decreased expression of striatal signaling genes in a mouse model of Huntington's disease HumMolGenet 9 1259 1271
34. Mantamadiotis T. Lemberger T. Bleckmann SC. Kern H. Kretz O. Martin VA. Tronche F. Kellendonk C. Gau D. Kapfhammer J. Otto C. Schmid W. Schutz G. 2002 Disruption of CREB function in brain leads to neurodegeneration Nature Genet 31 47 54
35. Meade CA. Figueredo-Cardenas G. Fusco F. Nowak TS. Jr. Pulsinelli WA. Reiner A. 2000 Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease ExpNeurol 166 307 323
36. Meyer TE. Habener JF. 1993 Cyclic adenosine 3′-5′ monophosphate response elemente binding protein (CREB) and related tramscription activating deoxyribonucleic acid-binding proteins EndocrRev 14 269 290
37. Nucifora FC. Jr. Sasaki M. Peters MF. Huang H. Cooper JK. Yamada M. Takahashi H. Tsuji S. Troncoso J. Dawson VL. Dawson TM. Ross CA. 2001 Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity Science 291 2423 2428
38. Pardon MC. Roberts RE. Marsden CA. Bianchi M. Latif ML. Duxon MS. Kendall DA. 2005 Social threat and novel cage stress-induced sustained extracellular-regulated kinase1/2 (ERK1/2) phosphorylation but differential modulation of brain-derived neurotrophic factor (BDNF) expression in the hippocampus of NMRI mice Neuroscience 132 561 574
39. Reiner A. Albin RL. Anderson KD. D'Amato CJ. Penney JB. Young AB. 1988 Differential loss of striatal projection neurons in Huntington disease ProcNatl AcadSciUSA 85 5733 5737
40. Shimohata T. Nakajima T. Yamada M. Uchida C. Onodera O. Naruse S. Kimura T. Koide R. Nozaki K. Sano Y. Ishiguro H. Sakoe K. Ooshima T. Sato A. Ikeuchi T. Oyake M. Sato T. Aoyagi Y. Hozumi I. Nagatsu T. Takiyama Y. Nishizawa M. Goto J. Kanazawa I. Davidson I. Tanese N. Takahashi H. Tsuji S. 2000 Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription Nature Genet 26 29 36
41. Sipione S. Rigamonti D. Valenza M. Zuccato C. Conti L. Pritchard J. Kooperberg C. Olson JM. Cattaneo E. 2002 Early transcriptional profiles in huntingtin-inducible striatal cells by microarray analyses HumMolGenet 11 1953 1965
42. Steffan JS. Bodai L. Pallos J. Poelman M. McCampbell A. Apostol BL. Kazantsev A. Schmidt E. Zhu YZ. Greenwald M. Kurokawa R. Housman DE. Jackson GR. Marsh JL. Thompson LM. 2001 Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila Nature 413 739 743
43. Steffan JS. Kazantsev A. Spasic-Boskovic O. Greenwald M. Zhu YZ. Gohler H. Wanker EE. Bates GP. Housman DE. Thompson LM. 2000 The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription ProcNatl AcadSciUSA 97 6763 6768
44. Sugars KL. Brown R. Cook LJ. Swartz J. Rubinsztein DC. 2004 Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis JBiolChem 279 4988 4999
45. Sugars KL. Rubinsztein DC. 2003 Transcriptional abnormalities in Huntington disease TIG 19 233 238
46. Tanaka K. Nogawa S. Nagata E. Ito D. Suzuki S. Dembo T. Kosakai A. Fukuuchi Y. 2000 Persistent CREB phosphorylation with protection of hippocampal CA1 pyramidal neurons following temporary occlusion of the middle cerebral artery in the rat Exp. Neurol. 161 462 471
47. Vonsattel JP. DiFiglia M. 1998 Huntington disease JNeuropatholExpNeurol 57 369 384
48. Vonsattel JP. Myers RH. Stevens TJ. Ferrante RJ. Bird ED. Richardson EP. Jr. 1985 Neuropathological classification of Huntington's disease JNeuropatholExpNeurol 44 559 577
49. Walton MR. Dragunow I. 2000 Is CREB a key to neuronal survival? TINS 23 48 53
50. Walton M. Sirimanne E. Williams C. Gluckman P. Dragunow M. 1996 The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair Brain ResMolBrain Res 43 21 29
51. Wilson RS. Como PG. Garron DC. Klawans HL. Barr A. Klawans D. 1987 Memory failure in Huntington's disease JClinExpNeuropsychol 9 147 154
52. Wyttenbach A. Swartz J. Kita H. Thykjaer T. Carmichael J. Bradley J. Brown R. Maxwell M. Schapira A. Orntoft TF. Kato K. Rubinsztein DC. 2001 Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease HumMolGenet 10 1829 1845
53. Zuccato C. Ciammola A. Rigamonti D. Leavitt BR. Goffredo D. Conti L. MacDonald ME. Friedlander RM. Silani V. Hayden MR. Timmusk T. Sipione S. Cattaneo E. 2001 Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease Science 293 493 498